Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Alkahest received early financing of $3.5M on 2014-08-01.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $3.5M | 08/2014 |
| Corporate Round | $37.5M | 03/2015 |
| Investors | Security type |
|---|---|
| Grifols | Corporate Round |
Alkahest's top competitor, Imago BioSciences, earned an annual revenue of $108.8M.
Alkahest's smallest competitor is Chimerix with revenue of $212.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Cognition Therapeutics | - | $19.5M | 30 | - |
| Chimerix | - | $212,000 | 82 | - |
| AZTherapies | - | $5.0M | 40 | - |
| Athira Pharma | - | $1.3M | 27 | - |
| Imago BioSciences | - | $108.8M | 14 | - |
| ArmaGen | - | $1.1M | 1 | - |
Zippia gives an in-depth look into the details of Alkahest, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Alkahest. The employee data is based on information from people who have self-reported their past or current employments at Alkahest. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Alkahest. The data presented on this page does not represent the view of Alkahest and its employees or that of Zippia.
Alkahest may also be known as or be related to Alkahest, Alkahest Inc and Alkahest, Inc.